drugset / Trial / NCT01175330

Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting

NCT01175330 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate efficacy of Polyunsaturated Fatty Acid for the prevention of Atrial Fibrillation and anti-inflammatory effects in patients after CABG surgery

Timeline

Start
2010-08
Primary completion
2012-12
Completion
2013-08

Outcome

Outcome not reported

Stopped: “Interim analysis did not reveal of anticipated benefits of intervention”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omegaven Other / unclassified 1 ml Intravenous
Comparator Omegaven Other / unclassified 100 mg/kg Intravenous